Mobile menu icon
Mobile menu icon Search iconSearch
Search type
A woman shaking tablets from a bottle into her hand.

Treatment effectiveness and safety

We aim to understand disease progression and prognosis for people living with musculoskeletal disease.

We do this by exploring:

  • biologic, biosimilar and new targeted therapies;
  • conventional synthetic anti-rheumatic drugs and glucocorticoids;
  • analgesics for chronic musculoskeletal pain; non-pharmacological treatments.

Key projects

The MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS) project (2015-2021) identified predictors of response to drugs in systemic lupus erythematosus (SLE) patients.

Visit the MASTERPLANS project website

Academic leads